Publications

Targeted degradation of oncogenic KRAS G12V triggers antitumor immunity in lung cancer models

 31
Targeted degradation of oncogenic KRAS G12V triggers antitumor immunity in lung cancer models

Tags:

Previous Article

Increased cholesterol synthesis drives neurotoxicity in multiple sclerosis

Next Article

Animal model for antitumor immunity in lung cancer

Related Posts

Lipids and chromatin: a tale of intriguing connections shaping genomic landscapes

Lipids and chromatin: a tale of intriguing connections ...

 22

An excitatory neural circuit for descending inhibition of itch processing

An excitatory neural circuit for descending inhibition ...

 37

Feeding gut microbes to nourish the brain: unravelling the diet–microbiota– gut–brain axis

Feeding gut microbes to nourish the brain: unravelling ...

 731